Tandem Diabetes Care (TNDM) Net Margin (2013 - 2026)
Tandem Diabetes Care's (TNDM) quarterly Net Margin came in at 8.25% in Q1 2026, up 4746.0% YoY from 0.17% in Q1 2025, and down 4312.82% on a QoQ basis from 0.19% in Q4 2025.
Tandem Diabetes Care (TNDM) Net Margin (2013 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has 14 years of Net Margin data on file, last reported at 8.25% in Q1 2026.
- Quarterly Net Margin rose 4746.0% year-over-year to 8.25% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 9.2% (up 951.0% YoY) and the FY2025 annual result came in at 20.17%, down 996.0% from the prior year.
- Net Margin eased to 8.25% in Q1 2026, from 0.19% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 0.27% in Q4 2024 to a low of 73.15% in Q1 2023.
- A 5-year average of 18.31% and a median of 13.89% in 2024 frame the typical range for Net Margin.
- Annual changes were most pronounced in 2023 — Net Margin slumped 6477 bps — and 2024, when it surged 5086 bps.
- Tracing TNDM's Net Margin over 5 years: stood at 7.21% in 2022, then tumbled by 111 bps to 15.23% in 2023, then jumped by 102 bps to 0.27% in 2024, then tumbled by 170 bps to 0.19% in 2025, then sank by 4313 bps to 8.25% in 2026.
- The last three Net Margin figures came in at 8.25% (Q1 2026), 0.19% (Q4 2025), and 8.49% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn | 7.37% |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn | 19.37% |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn | 12.84% |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | 16.67% |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | 13.87% |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | 19.04% |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn | 10.84% |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn | 6.47% |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | 13.47% |
| 10 | Tandem Diabetes Care | 1.56 Bn | 1.11 Bn | 144.78 Mn | -8.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -8.33% |
| Mar 31, 2026 | -8.25% |
| Dec 31, 2025 | -0.19% |
| Sep 30, 2025 | -8.49% |
| Jun 30, 2025 | -21.78% |
| Mar 31, 2025 | -55.71% |
| Dec 31, 2024 | 0.27% |
| Sep 30, 2024 | -9.52% |
| Jun 30, 2024 | -13.89% |
| Mar 31, 2024 | -22.29% |
| Dec 31, 2023 | -15.23% |
| Sep 30, 2023 | -17.76% |
| Jun 30, 2023 | -18.25% |
| Mar 31, 2023 | -73.15% |
| Dec 31, 2022 | -7.21% |
| Sep 30, 2022 | -23.93% |
| Jun 30, 2022 | -7.52% |
| Mar 31, 2022 | -8.38% |
| Dec 31, 2021 | 5.13% |
| Sep 30, 2021 | 3.20% |